Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study
Clinical trial NCT07778056 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07778056
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-20
- Primary completion
- 2027-12-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.